These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27879195)
1. Pharmacokinetic comparison and bioequivalence evaluation of two 10-mg baclofen formulations in healthy male subjects . Yoon S; Lee S; Yu KS; Yim SV; Kim BH Int J Clin Pharmacol Ther; 2017 Feb; 55(2):194-200. PubMed ID: 27879195 [TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of two formulations of pregabalin 150-mg capsules under fasting conditions in healthy male subjects . Lee HA; Lee S; Yim SV; Kim BH Int J Clin Pharmacol Ther; 2017 Feb; 55(2):171-176. PubMed ID: 28025964 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence of 0.5 mg lobeglitazone tablets in healthy male subjects . Lee SJ; Kim MG; Park SJ; Jeon JY Int J Clin Pharmacol Ther; 2018 Sep; 56(9):426-433. PubMed ID: 29932413 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and bioequivalence assessment of two formulations of tianeptine sodium in healthy male volunteers. Zheng R; Kim BH Int J Clin Pharmacol Ther; 2014 Sep; 52(9):817-23. PubMed ID: 25109511 [TBL] [Abstract][Full Text] [Related]
5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetic and bioequivalence evaluation of two formulations of morniflumate 350-mg tablets in healthy male subjects . Lee H; Yim SV; Kim BH; Lee S Int J Clin Pharmacol Ther; 2017 Jan; 55(1):95-101. PubMed ID: 27841153 [TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: a single-dose, randomized-sequence, open-label, two-period crossover trial. Yu JY; Song HH; Kim BG; Park HJ; Choi KS; Kwon YE Clin Ther; 2009 Nov; 31(11):2735-43. PubMed ID: 20110015 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjects. Kim KA; Lim YY; Kim SH; Park JY Clin Ther; 2013 Nov; 35(11):1752-61. PubMed ID: 24094463 [TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacokinetics and uric acid lowering effect between two different strength febuxostat formulations (80 mg vs. 40 mg) in healthy subjects. Kim KA; Park JY Int J Clin Pharmacol Ther; 2015 Aug; 53(8):667-73. PubMed ID: 25997544 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study. Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic comparisons of two acetyl-L-carnitine formulations in healthy Korean volunteers. Baek SM; Zheng R; Seo EJ; Hwang DY; Kim BH Int J Clin Pharmacol Ther; 2015 Nov; 53(11):980-6. PubMed ID: 26396135 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers. Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers. Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151 [TBL] [Abstract][Full Text] [Related]
14. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study. Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Jiang X; Bae S; Yoon DY; Park SJ; Oh J; Cho JY; Yu KS Drug Des Devel Ther; 2023; 17():2137-2145. PubMed ID: 37521035 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers. Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893 [TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of a single 400-mg dose of imatinib 100-mg oral tablets and a 400-mg tablet in healthy adult Korean volunteers. Lee HW; Seong SJ; Park SM; Lee J; Gwon MR; Kim HJ; Lim SM; Lim MS; Kim W; Yang DH; Yoon YR Int J Clin Pharmacol Ther; 2015 Jun; 53(6):480-7. PubMed ID: 25881751 [TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of two commercial amoxicillin suspension formulations in healthy human volunteers. Franco GC; Baglie S; Ruenis AP; Franco LM; Cogo K; Oshima-Franco Y; Silva P; Groppo FC; Rosalen PL Int J Clin Pharmacol Ther; 2014 May; 52(5):425-30. PubMed ID: 24755132 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers. Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]